Immune Thrombocytopenic Purpura

The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections. Journal of Clinical & Experimental Pathology covers all areas of clinical and experimental pathology. Articles such as research papers, review articles, commentaries and short communications leading to the development of Journal of clinical and experimental pathology.
Immune thrombocytopenic purpura (ITP), also known as idiopathic thrombocytopenic purpura, is a type of thrombocytopenic purpura defined as an isolated low platelet count with a normal bone marrow in the absence of other causes of low platelets. It causes a characteristic red or purple bruise-like rash and an increased tendency to bleed. Platelets are produced in the bone marrow. They help stop bleeding by clumping together to form a clot that seals cuts or small tears in blood vessel walls and tissues. If your blood doesn’t have enough platelets, it’s slow to clot. Internal bleeding or bleeding on or under the skin can result.
People with ITP often have many purple bruises called purpura on the skin or mucous membranes inside the mouth. These bruises may also appear as pinpoint-sized red or purple dots on the skin called petechiae. Petechiae often look like a rash. ITP can occur in both children and adults. There appears to be differences at certain ages between women and men and the development of ITP. At younger ages, ITP may be more common in women. At older ages, it may be more common in men. Children are most likely to develop this condition after a general viral illness. Some specific viruses, such as chickenpox, mumps, and measles, have been linked to ITP as well.
Immune thrombocytopenia may have no signs and symptoms. But some of the seen symptoms may include: Easy or excessive bruising, Superficial bleeding into the skin that appears as pinpoint-sized reddish-purple spots (petechiae) that look like a rash, usually on the lower legs, Bleeding from the gums or nose, Blood in urine or stools, Unusually heavy menstrual flow, prolonged bleeding from cuts and profuse bleeding during surgery.
Diagnosis of immune thrombocytopenic purpura includes a complete physical exam. They’ll ask you about your medical history and the medications you’re taking and also may conduct blood tests that include a complete blood count. The blood tests may also include tests to evaluate your liver and kidney function, depending on your symptoms. A follow-up blood test that checks for platelet antibodies may also be recommended. They also request a blood smear, in which some of your blood is placed on a glass slide and viewed under a microscope to verify the number and appearance of platelets seen in the complete blood count. If you have a low platelet count, your doctor may also order a bone marrow test. If you have ITP, your bone marrow will be normal. This is because your platelets are destroyed in the bloodstream and spleen after they leave the bone marrow. If your bone marrow is abnormal, your low platelet count will likely be caused by another disease, rather than ITP.
Children that develop the acute form of ITP usually recover within six months or less without any treatment. Adults with less severe cases of ITP may also not require treatment. However, your doctor will still want to monitor your platelet and red blood cell count to make sure you don’t need treatment in the future.
On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.
Regards,
Robert Solomon
Editorial office
Journal of Clinical and Experimental Pathology
E-mail: pathol@eclinicalsci.com
Reach Us: +1-947-333-4405